vs

Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and Grand Canyon Education, Inc. (LOPE). Click either name above to swap in a different company.

Grand Canyon Education, Inc. is the larger business by last-quarter revenue ($308.1M vs $236.8M, roughly 1.3× CROSS COUNTRY HEALTHCARE INC). Grand Canyon Education, Inc. runs the higher net margin — 28.1% vs -35.0%, a 63.2% gap on every dollar of revenue. On growth, Grand Canyon Education, Inc. posted the faster year-over-year revenue change (5.3% vs -23.6%). Grand Canyon Education, Inc. produced more free cash flow last quarter ($122.9M vs $16.1M). Over the past eight quarters, Grand Canyon Education, Inc.'s revenue compounded faster (5.9% CAGR vs -21.0%).

GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...

Grand Canyon Education, Inc. (GCE) is an American for-profit corporation that provides services to universities, specializing in program development, online education, and operational support. Formerly affiliated with Grand Canyon University (GCU), a Christian university in Arizona, GCE became a separate publicly traded company in 2008.

CCRN vs LOPE — Head-to-Head

Bigger by revenue
LOPE
LOPE
1.3× larger
LOPE
$308.1M
$236.8M
CCRN
Growing faster (revenue YoY)
LOPE
LOPE
+28.9% gap
LOPE
5.3%
-23.6%
CCRN
Higher net margin
LOPE
LOPE
63.2% more per $
LOPE
28.1%
-35.0%
CCRN
More free cash flow
LOPE
LOPE
$106.7M more FCF
LOPE
$122.9M
$16.1M
CCRN
Faster 2-yr revenue CAGR
LOPE
LOPE
Annualised
LOPE
5.9%
-21.0%
CCRN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CCRN
CCRN
LOPE
LOPE
Revenue
$236.8M
$308.1M
Net Profit
$-82.9M
$86.7M
Gross Margin
Operating Margin
-30.2%
35.1%
Net Margin
-35.0%
28.1%
Revenue YoY
-23.6%
5.3%
Net Profit YoY
-2109.7%
5.9%
EPS (diluted)
$-2.56
$3.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCRN
CCRN
LOPE
LOPE
Q4 25
$236.8M
$308.1M
Q3 25
$250.1M
$261.1M
Q2 25
$274.1M
$247.5M
Q1 25
$293.4M
$289.3M
Q4 24
$309.9M
$292.6M
Q3 24
$315.1M
$238.3M
Q2 24
$339.8M
$227.5M
Q1 24
$379.2M
$274.7M
Net Profit
CCRN
CCRN
LOPE
LOPE
Q4 25
$-82.9M
$86.7M
Q3 25
$-4.8M
$16.3M
Q2 25
$-6.7M
$41.5M
Q1 25
$-490.0K
$71.6M
Q4 24
$-3.8M
$81.9M
Q3 24
$2.6M
$41.5M
Q2 24
$-16.1M
$34.9M
Q1 24
$2.7M
$68.0M
Gross Margin
CCRN
CCRN
LOPE
LOPE
Q4 25
Q3 25
20.4%
Q2 25
20.4%
Q1 25
20.0%
Q4 24
Q3 24
20.4%
Q2 24
20.8%
Q1 24
20.4%
Operating Margin
CCRN
CCRN
LOPE
LOPE
Q4 25
-30.2%
35.1%
Q3 25
-2.4%
6.9%
Q2 25
-2.1%
20.9%
Q1 25
-0.3%
30.4%
Q4 24
-1.1%
34.2%
Q3 24
0.9%
20.2%
Q2 24
-5.7%
18.8%
Q1 24
0.8%
30.8%
Net Margin
CCRN
CCRN
LOPE
LOPE
Q4 25
-35.0%
28.1%
Q3 25
-1.9%
6.2%
Q2 25
-2.4%
16.8%
Q1 25
-0.2%
24.8%
Q4 24
-1.2%
28.0%
Q3 24
0.8%
17.4%
Q2 24
-4.7%
15.3%
Q1 24
0.7%
24.8%
EPS (diluted)
CCRN
CCRN
LOPE
LOPE
Q4 25
$-2.56
$3.13
Q3 25
$-0.15
$0.58
Q2 25
$-0.20
$1.48
Q1 25
$-0.02
$2.52
Q4 24
$-0.13
$2.83
Q3 24
$0.08
$1.42
Q2 24
$-0.47
$1.19
Q1 24
$0.08
$2.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCRN
CCRN
LOPE
LOPE
Cash + ST InvestmentsLiquidity on hand
$108.7M
$111.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$322.8M
$746.9M
Total Assets
$449.0M
$992.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCRN
CCRN
LOPE
LOPE
Q4 25
$108.7M
$111.8M
Q3 25
$99.1M
$97.3M
Q2 25
$81.2M
$192.3M
Q1 25
$80.7M
$144.5M
Q4 24
$81.6M
$324.6M
Q3 24
$64.0M
$263.6M
Q2 24
$69.6M
$241.3M
Q1 24
$5.2M
$196.2M
Stockholders' Equity
CCRN
CCRN
LOPE
LOPE
Q4 25
$322.8M
$746.9M
Q3 25
$408.1M
$758.0M
Q2 25
$412.2M
$778.0M
Q1 25
$418.2M
$780.7M
Q4 24
$419.0M
$783.9M
Q3 24
$424.7M
$764.1M
Q2 24
$433.3M
$759.2M
Q1 24
$462.4M
$759.4M
Total Assets
CCRN
CCRN
LOPE
LOPE
Q4 25
$449.0M
$992.3M
Q3 25
$538.2M
$1.0B
Q2 25
$553.8M
$1.0B
Q1 25
$576.2M
$1.0B
Q4 24
$589.3M
$1.0B
Q3 24
$597.4M
$992.9M
Q2 24
$602.9M
$992.7M
Q1 24
$648.4M
$1.0B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCRN
CCRN
LOPE
LOPE
Operating Cash FlowLast quarter
$18.2M
$130.5M
Free Cash FlowOCF − Capex
$16.1M
$122.9M
FCF MarginFCF / Revenue
6.8%
39.9%
Capex IntensityCapex / Revenue
0.9%
2.5%
Cash ConversionOCF / Net Profit
1.50×
TTM Free Cash FlowTrailing 4 quarters
$40.1M
$238.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCRN
CCRN
LOPE
LOPE
Q4 25
$18.2M
$130.5M
Q3 25
$20.1M
$-48.6M
Q2 25
$4.2M
$124.0M
Q1 25
$5.7M
$67.6M
Q4 24
$24.2M
$135.8M
Q3 24
$7.5M
$-29.4M
Q2 24
$82.4M
$98.6M
Q1 24
$6.0M
$85.0M
Free Cash Flow
CCRN
CCRN
LOPE
LOPE
Q4 25
$16.1M
$122.9M
Q3 25
$17.9M
$-58.3M
Q2 25
$2.3M
$115.4M
Q1 25
$3.8M
$58.7M
Q4 24
$21.7M
$126.1M
Q3 24
$6.3M
$-39.0M
Q2 24
$79.6M
$89.6M
Q1 24
$3.8M
$76.0M
FCF Margin
CCRN
CCRN
LOPE
LOPE
Q4 25
6.8%
39.9%
Q3 25
7.2%
-22.3%
Q2 25
0.8%
46.6%
Q1 25
1.3%
20.3%
Q4 24
7.0%
43.1%
Q3 24
2.0%
-16.3%
Q2 24
23.4%
39.4%
Q1 24
1.0%
27.7%
Capex Intensity
CCRN
CCRN
LOPE
LOPE
Q4 25
0.9%
2.5%
Q3 25
0.9%
3.7%
Q2 25
0.7%
3.5%
Q1 25
0.6%
3.1%
Q4 24
0.8%
3.3%
Q3 24
0.4%
4.0%
Q2 24
0.8%
3.9%
Q1 24
0.6%
3.3%
Cash Conversion
CCRN
CCRN
LOPE
LOPE
Q4 25
1.50×
Q3 25
-2.99×
Q2 25
2.98×
Q1 25
0.94×
Q4 24
1.66×
Q3 24
2.92×
-0.71×
Q2 24
2.83×
Q1 24
2.23×
1.25×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CCRN
CCRN

Temporary Staffing Services$189.6M80%
Physician Staffing$42.5M18%
Other Services$4.7M2%

LOPE
LOPE

Segment breakdown not available.

Related Comparisons